Does OLAPARIB Cause Peripheral swelling? 138 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 138 reports of Peripheral swelling have been filed in association with OLAPARIB (Lynparza). This represents 0.8% of all adverse event reports for OLAPARIB.
138
Reports of Peripheral swelling with OLAPARIB
0.8%
of all OLAPARIB reports
6
Deaths
39
Hospitalizations
How Dangerous Is Peripheral swelling From OLAPARIB?
Of the 138 reports, 6 (4.3%) resulted in death, 39 (28.3%) required hospitalization, and 4 (2.9%) were considered life-threatening.
Is Peripheral swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLAPARIB. However, 138 reports have been filed with the FAERS database.
What Other Side Effects Does OLAPARIB Cause?
Death (4,378)
Malignant neoplasm progression (1,862)
Nausea (1,582)
Anaemia (1,455)
Fatigue (1,437)
Off label use (777)
Vomiting (642)
Drug ineffective (563)
Diarrhoea (514)
Asthenia (491)
What Other Drugs Cause Peripheral swelling?
ADALIMUMAB (13,837)
ETANERCEPT (12,654)
METHOTREXATE (10,632)
TOCILIZUMAB (8,030)
TOFACITINIB (7,830)
ABATACEPT (7,561)
LEFLUNOMIDE (7,254)
LENALIDOMIDE (6,364)
HYDROXYCHLOROQUINE (6,128)
RITUXIMAB (5,977)
Which OLAPARIB Alternatives Have Lower Peripheral swelling Risk?
OLAPARIB vs OLARATUMAB
OLAPARIB vs OLECLUMAB
OLAPARIB vs OLIVE OIL\SOYBEAN OIL
OLAPARIB vs OLMESARTAN
OLAPARIB vs OLMESARTAN MEDOXOMIL